Archive | News-Archiv-2012

3rd CI-3 CIuster Conference Showcases Projects and Partners

TRON participates with posters and presentations Mainz, Germany, November 19, 2012 – On December 5, the Cluster for Individualized ImmunIntervention (CI-3) hosts a conference for participating partners and networks to present all projects sponsored by the German Federal Ministry of Education and Research. The meeting will take place at Kurfürstliches Schloss in Mainz and…

Continue Reading

New confidence score to rank somatic mutations

Mainz, Germany, October 2, 2012 – TRON scientists have pioneered a statistical framework that enables researchers to reduce the number of false discovery rates for tumor mutations. The method was published in the September issue of PLOS Computational Biology. While next generation sequencing (NGS) has enabled the highly accurate, unbiased, and high throughput discovery of

Continue Reading

The T cell druggable genome – a new target space for cancer drugs

Mainz, Germany, September 6, 2012 – The emerging era of individualized cancer immunotherapy is dramatically changing the target landscape by adding targets that can be recognized by antibodies and T cells, thus significantly increasing the number of druggable tumor targets. In a recent article in the European Pharmaceutical Review, TRON scientists describe a process to

Continue Reading